COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,680 Articles (22,913 medRxiv, 8,767 bioRxiv)

Most recent first Previous |  Page 149: Articles 1481-1490  | Next

The physio-affective symptoms of Long COVID are strongly predicted by the severity of the acute infectious phase, and lowered antioxidants, nitric oxide, and alanine transaminase levels.
Maes, M., Tunvirachaisakul, C., Semeao, L. d. O., Michelin, A. P., Matsumoto, A. K., Brinholi, F. F., Barbosa, D. S., Zhang, Y., Sodsai, P., Hirankarn, N., Almulla, A. F.
10.1101/2025.02.07.25321870 — Posted: 2025-02-08
Vaccine Effectiveness Among 5- to 17-year-old Individuals with Prior SARS-CoV-2 Infection: An EHR-Based Target Trial Emulation Study from the RECOVER Project
Chen, J., Lei, Y., Wu, Q., Zhou, T., Zhang, B., Becich, M. J., Bisyuk, Y., Blecker, S., Chrischilles, E. A., Christakis, D. A., Cowell, L. G., Cummins, M. R., Fernandez, S. A., Fort, D., Gonzalez, S., Herring, S. J., Horne, B. D., Horowitz, C., Liu, M., Kim, S., Mirhaji, P., Mosa, A. S. M., Muszynski, J. A., Paules, C. I., Sato, A., Schwenk, H. T., Sengupta, S., Suresh, S., Taylor, B. W., Williams, D. A., He, Y., Morris, J. S., Jhaveri, R., Forrest, C. B., Chen, Y.
10.1101/2025.02.07.25321814 — Posted: 2025-02-08
Longitudinal epigenetic rewiring in lung immune cells in patients with post-COVID-19 condition
Nikesjö, F., Smiljanic, J., Sayyab, s., Martinez-Enguita, D., Gustafsson, M., Rosvall, M., Hedman, K., Lerm, M.
10.1101/2025.02.06.25321750 — Posted: 2025-02-07
AVERTED MORTALITY BY COVID-19 VACCINATION IN BELGIUM BETWEEN 2021 AND 2023
Stouten, V., Van Evercooren, I., Vernemmen, C., Braeye, T., Catteau, L., Roelants, M., Billuart, M., Lamot, T., Bustos Sierra, N., Hammami, N., Vermeiren, E., Rosas, A., Blot, K., Schmelz, A. I., Nasiadka, L., Nganda, S., van Loenhout, J. A. F.
10.1101/2025.02.06.25321208 — Posted: 2025-02-07
'Trans-differentiation of neutrophils from plasmablast' is an artefact caused by over-reliance on machine algorithms in single cell RNA sequencing analysis: Lesson learnt and steps ahead
Huang, J., Yam, P. S. C., Tang, N. L.-s.
10.1101/2025.02.07.636761 — Posted: 2025-02-07
DAZAP2 functions as a pan-coronavirus restriction factor by inhibiting viral entry and genomic replication
Feng, F., Chen, J., Li, R., Zhu, Y., Ma, Y., Wang, Z., Wang, Y., Gao, Z., Yang, L., Yu, Y., Liu, Y., Sun, Y., Liao, Y., Huang, X., Zhang, Q., Huang, Y., Qiu, L., Wu, J., Zhao, J., Liu, C., Ding, Q., Xie, Y., Yuan, Z., Hong, Y., Zhang, P., Sun, J., Zhao, J., Zhang, R.
10.1101/2025.02.04.636569 — Posted: 2025-02-07
Reproducibility of Genetic Risk Factors Identified for Long COVID using Combinatorial Analysis Across US and UK Patient Cohorts with Diverse Ancestries
Sardell, J., Pearson, M., Chocian, K., Das, S., Taylor, K., Strivens, M., Gupta, R., Rochlin, A., Gardner, S.
10.1101/2025.02.04.25320937 — Posted: 2025-02-06
Longitudinal evaluation of anti-SARS-CoV-2 neutralizing antibody levels in 3-dose homologous (mRNA-1273- mRNA-1273- BNT162b2) vaccinated Kidney transplant population: 18-month follow-up.
Karunathilake, R. P., Kumara, A., Karunathilake, A., Wazil, A. W., Nanayakkara, N., Bandara, K., Abeysekara, R., Noordeen, F., Gawarammana, I. B., Ratnatunga, C. N.
10.1101/2025.02.05.25321720 — Posted: 2025-02-06
P3a site-specific or cassette mutagenesis for seamless protein and plasmid engineering
Yang, X.-J.
10.1101/2025.02.03.636246 — Posted: 2025-02-06
Impact of Ebola and COVID-19 pandemic on patterns in uptake of short-acting and long-acting contraceptive methods in Sierra Leone: a country-wide observational study
Kamara, I. M., Molleh, B., Lakoh, S., Sevalie, S., Kenneh, S. M., Chan, A. K., Mishra, S., Moses, F., Bah, A. J.
10.1101/2025.02.04.25321692 — Posted: 2025-02-05

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).